4) Although the use of glucose-lowering or insulin medications improves insulin resistance and ameliorates vascular inflammation and arterial calcification, long-term use of such medications, especially sodium-glucose cotransporter 2 inhibitors and sulfonylureas, may induce local inflammation, thus influencing the progression of arterial calcification [66]. This evidence concerns the gene SLC5A2 and Insulin resistance.